Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?

被引：1
作者：
Saydan, Betuel [1 ]
Ozmen, Deniz [2 ]
Eskazan, Ahmet Emre [2 ]
机构：
[1] Ankara Univ, Fac Med, Ankara, Turkiye
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Internal Med, Div Hematol, Istanbul, Turkiye
来源：
EXPERT REVIEW OF HEMATOLOGY | 2024年 / 17卷 / 07期
关键词：
Chronic myeloid leukemia; CML; dasatinib; low-dose; 50; mg; CHRONIC LYMPHOCYTIC-LEUKEMIA; DECISION-SUPPORT-SYSTEM; SURVIVAL; CLL; INCORPORATE; PREFERENCES; POPULATION; GUIDELINES; IBRUTINIB; LYMPHOMA;
D O I：
10.1080/17474086.2024.2370556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 277
页数：3
相关论文
共 14 条
[1]   Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial [J].
Cortes, Jorge E. ;
Saglio, Giuseppe ;
Kantarjian, Hagop M. ;
Baccarani, Michele ;
Mayer, Jiri ;
Boque, Concepcion ;
Shah, Neil P. ;
Chuah, Charles ;
Casanova, Luis ;
Bradley-Garelik, Brigid ;
Manos, George ;
Hochhaus, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) :2333-U54
[2]   Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it? [J].
Eskazan, Ahmet Emre .
CANCER, 2018, 124 (21) :4260-4261
[3]   Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy [J].
Eskazan, Ahmet Emre ;
Soysal, Teoman ;
Ongoren, Seniz ;
Gulturk, Entine ;
Ferhanoglu, Burhan ;
Aydin, Yildiz .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03) :E15-E15
[4]   Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results [J].
Gener-Ricos, Georgina ;
Haddad, Fadi G. ;
Sasaki, Koji ;
Issa, Ghayas C. ;
Skinner, Jeffrey ;
Masarova, Lucia ;
Borthakur, Gautam ;
Alvarado, Yesid ;
Garcia-Manero, Guillermo ;
Jabbour, Elias ;
Kantarjian, Hagop .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (10) :742-748
[5]   Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study [J].
Iurlo, Alessandra ;
Cattaneo, Daniele ;
Artuso, Silvia ;
Consonni, Dario ;
Abruzzese, Elisabetta ;
Binotto, Gianni ;
Bocchia, Monica ;
Bonifacio, Massimiliano ;
Castagnetti, Fausto ;
Galimberti, Sara ;
Gozzini, Antonella ;
Iezza, Miriam ;
Latagliata, Roberto ;
Luciano, Luigiana ;
Maggi, Alessandro ;
Miggiano, Maria Cristina ;
Pregno, Patrizia ;
Rege-Cambrin, Giovanna ;
Russo, Sabina ;
Scortechini, Anna Rita ;
Tafuri, Agostino ;
Tiribelli, Mario ;
Fava, Carmen ;
Rosti, Gianantonio ;
Foa, Robin ;
Breccia, Massimo ;
Saglio, Giuseppe .
FRONTIERS IN ONCOLOGY, 2022, 12
[6]   Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia [J].
Jabbour, Elias ;
Haddad, Fadi G. ;
Sasaki, Koji ;
Carter, Bing Z. ;
Alvarado, Yesid ;
Nasnas, Cedric ;
Nasr, Lewis ;
Masarova, Lucia ;
Daver, Naval ;
Pemmaraju, Naveen ;
Short, Nicholas J. ;
Skinner, Jeffrey ;
Kadia, Tapan ;
Borthakur, Gautam ;
Garcia-Manero, Guillermo ;
Ravandi, Farhad ;
Issa, Ghayas C. ;
Andreeff, Michael ;
Kantarjian, Hagop .
CANCER, 2024, 130 (15) :2652-2659
[7]   Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis [J].
Jabbour, Elias ;
Sasaki, Koji ;
Haddad, Fadi G. ;
Issa, Ghayas C. ;
Skinner, Jeffrey ;
Dellasala, Sara ;
Yilmaz, Musa ;
Ferrajoli, Alessandra ;
Bose, Prithviraj ;
Thompson, Philip ;
Alvarado, Yesid ;
Jain, Nitin ;
Garcia-Manero, Guillermo ;
Takahashi, Koichi ;
Borthakur, Gautam ;
Pemmaraju, Naveen ;
Pierce, Sherry ;
Kantarjian, Hagop .
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) :1413-1418
[8]   Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia [J].
Kantarjian, Hagop ;
Shah, Neil P. ;
Hochhaus, Andreas ;
Cortes, Jorge ;
Shah, Sandip ;
Ayala, Manuel ;
Moiraghi, Beatriz ;
Shen, Zhixiang ;
Mayer, Jiri ;
Pasquini, Ricardo ;
Nakamae, Hirohisa ;
Huguet, Francoise ;
Boque, Concepcion ;
Chuah, Charles ;
Bleickardt, Eric ;
Bradley-Garelik, M. Brigid ;
Zhu, Chao ;
Szatrowski, Ted ;
Shapiro, David ;
Baccarani, Michele .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24) :2260-2270
[9]   Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations [J].
Keskin, Dilek ;
Sadri, Sevil ;
Eskazan, Ahmet Emre .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 :3355-3361
[10]  
Murai K, 2021, LANCET HAEMATOL, V8, pE902, DOI 10.1016/S2352-3026(21)00333-1
12